Blood-rsCDM: a new rapid and simplified carbapenemase detection method for detecting carbapenemases in Enterobacterales directly from positive blood cultures.


Journal

BMC microbiology
ISSN: 1471-2180
Titre abrégé: BMC Microbiol
Pays: England
ID NLM: 100966981

Informations de publication

Date de publication:
16 Oct 2024
Historique:
received: 31 08 2023
accepted: 26 09 2024
medline: 17 10 2024
pubmed: 17 10 2024
entrez: 16 10 2024
Statut: epublish

Résumé

We aim to validate and evaluate a new rapid and simplified method, called Blood-rsCDM, for the detection and characterization of carbapenemase using 3-aminophenylboronic acid (APBA) and ethylenediaminetetraacetic acid (EDTA) β-lactamase inhibitors from positive blood cultures. We utilized a panel of 172 Enterobacterales strains, including blaKPC (77), blaNDM (48), blaIMP (9), blaVIM (2), blaOXA-181 (2), blaKPC and blaNDM (6), as well as 28 carbapenem-susceptible Enterobacterales isolates, to assess the performance of Blood-rsCDM and the EDTA-carbapenem inactivation method (eCIM). Carbapenemase class was determined using specific inhibitors at 4 h and 6 h by Blood-rsCDM. Blood-rsCDM exhibited a sensitivity of 97.9% at both time points, with a specificity of 100%, regardless of the culture duration. The sensitivity of eCIM was 94.4%, with a specificity of 100%. Blood-rsCDM accurately characterized KPC-producing isolates as 77/77, metallo-β-lactamases (MBLs) as 58/59, and KPC and NDM carbapenemases as 6/6 at 4 h. There was no difference in results between the 4 h and 6 h time points. However, Blood-rsCDM could not differentiate OXA-181-producing strains. For eCIM, the characterization numbers for KPC-, OXA-181-, and MBLs-producing strains were 77/77, 2/2, and 57/59, respectively, but it failed to detect the coproduction of KPC and NDM isolates. Blood-rsCDM accurately discriminates carbapenemase within 4 h and is capable of directly differentiating multi-enzyme (KPC and NDM) presence from positive blood culture broths. Therefore, Blood-rsCDM represents a rapid, simple, easy-to-read, and accurate tool that can be utilized in resource-limited settings.

Identifiants

pubmed: 39415086
doi: 10.1186/s12866-024-03553-5
pii: 10.1186/s12866-024-03553-5
doi:

Substances chimiques

beta-Lactamases EC 3.5.2.6
carbapenemase EC 3.5.2.6
Bacterial Proteins 0
Boronic Acids 0
Edetic Acid 9G34HU7RV0
3-aminobenzeneboronic acid 30418-59-8
beta-Lactamase Inhibitors 0
Carbapenems 0
Anti-Bacterial Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

410

Informations de copyright

© 2024. The Author(s).

Références

Tamma PD, Goodman KE, Harris AD, Tekle T, Roberts A, Taiwo A, Simner PJ. Comparing the outcomes of patients with carbapenemase-producing and non-carbapenemase-producing Carbapenem-Resistant Enterobacteriaceae Bacteremia. Clin Infect Dis. 2017;64(3):257–64.
doi: 10.1093/cid/ciw741 pubmed: 28013264
Kern WV, Rieg S. Burden of bacterial bloodstream infection-a brief update on epidemiology and significance of multidrµg-resistant pathogens. Clin Microbiol Infect. 2020;26(2):151–7.
doi: 10.1016/j.cmi.2019.10.031 pubmed: 31712069
Wong GTF, Villois P, Scheetz MH, Rhodes NJ, Briscoe S, McWhinney B, Nunez-Nunez M, Ungerer J, Lipman J, Roberts JA. β-Lactam pharmacodynamics in Gram-negative bloodstream infections in the critically ill. J Antimicrob Chemother. 2020;75(2):429–43.
pubmed: 31665353
Bush K, Fisher J. Epidemiological expansion, structural studies, and clinical challenges of new β-lactamases from gram-negative bacteria. Annu Rev Microbiol. 2011;65:455–78.
doi: 10.1146/annurev-micro-090110-102911 pubmed: 21740228
RP A. The structure of beta-lactamases. Philos Trans R Soc Lond B Biol Sci. 1980;289:321–31.
doi: 10.1098/rstb.1980.0049
Tilahun M, Kassa Y, Gedefie A, Ashagire M. Emerging carbapenem-resistant Enterobacteriaceae infection, its epidemiology and Novel Treatment options: a review. Infect Drµg Resist. 2021;14:4363–74.
doi: 10.2147/IDR.S337611
Ledeboer NA, Lopansri BK, Dhiman N, Cavagnolo R, Carroll KC, Granato P, Thomson R, Jr, Butler-Wu SM, Berger H, Samuel L, et al. Identification of Gram-negative Bacteria and genetic resistance determinants from positive blood culture broths by Use of the Verigene Gram-negative blood culture multiplex microarray-based molecular assay. J Clin Microbiol. 2015;53(8):2460–72.
doi: 10.1128/JCM.00581-15 pubmed: 25994165 pmcid: 4508435
Hossein Salimnia MRF, Paul R, Lephart P, Schreckenberger SM, DesJarlais JK, Johnson G, Robinson KC, Carroll A, Greer M, Morgan R, Chan M, Loeffelholz F, Valencia-Shelton S, Jenkins, Audrey N, Schuetz, Judy A, Daly. Trenda Barney, Andrew Hemmert, Kristen J Kanack. Evaluation of the FilmArray Blood Culture Identification Panel: results of a Multicenter Controlled Trial. J Clin Microbiol. 2016;54(3):687–98.
doi: 10.1128/JCM.01679-15 pubmed: 26739158 pmcid: 4767991
Takissian J, Bonnin RA, Naas T, Dortet L. NG-Test Carba 5 for Rapid Detection of Carbapenemase-Producing Enterobacterales from positive blood cultures. Antimicrob Agents Chemother. 2019;63(5):e00011–19.
doi: 10.1128/AAC.00011-19 pubmed: 30803973 pmcid: 6496082
Bianco G, Boattini M, van Asten SAV, Iannaccone M, Zanotto E, Zaccaria T, Bernards AT, Cavallo R, Costa C. RESIST-5 O.O.K.N.V. and NG-Test Carba 5 assays for the rapid detection of carbapenemase-producing enterobacterales from positive blood cultures: a comparative study. J Hosp Infect. 2020;105(2):162–6.
doi: 10.1016/j.jhin.2020.03.022 pubmed: 32304724
Figueroa-Espinosa R, Costa A, Cejas D, Barrios R, Vay C, Radice M, Gutkind G, Di Conza J. MALDI-TOF MS based procedure to detect KPC-2 directly from positive blood culture bottles and colonies. J Microbiol Methods. 2019;159:120–7.
doi: 10.1016/j.mimet.2019.02.020 pubmed: 30849422
Gabriele Bianco SC, Boattini M, Ricciardelli G, Guarrasi L, Cavallo R, Costa C. MALDI-TOF MS-Based approaches for direct identification of Gram-negative Bacteria and BlaKPC-Carrying plasmid detection from blood cultures: a three-year single-centre study and proposal of a diagnostic algorithm. Microorganisms. 2022;29(1):91.
doi: 10.3390/microorganisms11010091
Gabriele Bianco MB, Iannaccone M, Zanotto E, Cavallo R. Direct ethylenediaminetetraaceticacid-modified β-Lactam inactivation method: an Improved Method to identify serine-Carbapenemase-, Metallo-β-Lactamase-, and extended-Spectrum-β-Lactamase-producing enterobacterales directly from positive blood culture. Microb Drµg Resist. 2021;27(6):740–6.
doi: 10.1089/mdr.2020.0343
Sfeir MM, Satlin MJ, Fauntleroy KA, Jenkins SG, Westblade LF. Blood-modified carbapenem inactivation method: a phenotypic method for detecting carbapenemase-producing Enterobacteriaceae directly from positive blood culture broths. J Clin Microbiol 2020; 58(2).
Bianco GBM, Iannaccone M, Fossati L, Cavallo R, Costa C. Direct β-Lactam inactivation method: a new low-cost assay for Rapid Detection of Carbapenemase- or extended-Spectrum-β-Lactamase-producing enterobacterales directly from positive blood culture bottles. J Clin Microbiol. 2020;58(1):e01178–19.
Keshta AS, Elamin N, Hasan MR, Perez-Lopez A, Roscoe D, Tang P, Suleiman M. Evaluation of Rapid Immunochromatographic tests for the direct detection of Extended Spectrum Beta-Lactamases and Carbapenemases in Enterobacterales isolated from positive blood cultures. Microbiol Spectr. 2021;9(3):e0078521.
doi: 10.1128/Spectrum.00785-21 pubmed: 34878297
Liao Q, Yuan Y, Zhang W, Deng J, Wu S, Liu Y, Xiao Y, Kang M. Detection and characterization of Carbapenemases in Enterobacterales with a New Rapid and Simplified Carbapenemase Detection Method called rsCDM. Front Microbiol. 2022;13:860288.
doi: 10.3389/fmicb.2022.860288 pubmed: 35572690 pmcid: 9097014
Liao Q, Yuan Y, Li Q, Wu S, Liu Y, Zhang W, Xiao Y, Kang M. Comparing three different phenotypic methods for accurate detection of carbapenemase-producing enterobacterales. J Infect Chemother. 2021;27(6):794–9.
doi: 10.1016/j.jiac.2021.01.003 pubmed: 33468425
Giske CG, Gezelius L, Samuelsen Ø, Warner M, Sundsfjord A, Woodford N. A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid and cloxacillin. Clin Microbiol Infect. 2011;17(4):552–6.
doi: 10.1111/j.1469-0691.2010.03294.x pubmed: 20597925
Wayne PA. CLSI Performance standards for Antimicrobial susceptibility testing CLSI supplement M100, 2022, 32th edn. Clinical and Laboratory Standards Institute.
Huang Y, Li J, Wang Q, Tang K, Cai X, Li C. Detection of carbapenem-resistant hypervirulent Klebsiella pneumoniae ST11-K64 co-producing NDM-1 and KPC-2 in a tertiary hospital in Wuhan. J Hosp Infect. 2023;131:70–80.
doi: 10.1016/j.jhin.2022.09.014 pubmed: 36183928
Fang Rong ZL, Pengbin Yang F, Wu Y, Sun XS, Zhou J. Epidemiological and molecular characteristics of blaNDM-1 and blaKPC-2 Co-occurrence Carbapenem-resistant Klebsiella pneumoniae. Infect Drµg Resist. 2023;16:2247–58.
doi: 10.2147/IDR.S400138
Vásquez-Ponce FDK, Becerra J, Melocco G, Esposito F, Cardoso B, Rodrigues L, Lima K, de Lima AV, Sellera FP, Mattos R, Trevisoli L, Vianello MA, Sincero T, Di Conza J, Vespero E, Gutkind G, Sampaio J, Lincopan N. Detecting KPC-2 and NDM-1 coexpression in Klebsiella pneumoniae Complex from Human and Animal Hosts in South America. Microbiol Spectr. 2022;10(5):e01159–22.
doi: 10.1128/spectrum.01159-22 pubmed: 35980188 pmcid: 9604071

Auteurs

Quanfeng Liao (Q)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.

Xingqin Yi (X)

Pengzhou Maternal and Child Care Hospital, Pengzhou Woman and Childrens Hospital, Pengzhou, China.

Yu Yuan (Y)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.

Weili Zhang (W)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.

Jin Deng (J)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.

Siying Wu (S)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.

Ya Liu (Y)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China.

Mei Kang (M)

Department of Laboratory Medicine, West China Hospital, Sichuan University, Chengdu, China. kangmei@sina.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH